Immunopathogenesis of Myasthenia Gravis
- 14 March 2018
- book chapter
- Published by Springer Nature
- p. 47-60
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Circulating miRNAs in myasthenia gravis: miR‐150‐5p as a new potential biomarkerAnnals of Clinical and Translational Neurology, 2013
- Th17 Cells in Immunity and AutoimmunityJournal of Immunology Research, 2013
- Nicotinic acetylcholine receptor and the structural basis of neuromuscular transmission: insights fromTorpedopostsynaptic membranesQuarterly Reviews of Biophysics, 2013
- The Transcription Factors Egr2 and Egr3 Are Essential for the Control of Inflammation and Antigen-Induced Proliferation of B and T CellsImmunity, 2012
- Autoimmune myasthenia gravis: emerging clinical and biological heterogeneityThe Lancet Neurology, 2009
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSKCell, 2008
- IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†Brain, 2008
- Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactivation of MuSKMolecular and Cellular Neuroscience, 2006
- The Receptor Tyrosine Kinase MuSK Is Required for Neuromuscular Junction Formation In VivoCell, 1996